EUVIMEDEUVIMED entdecken
Crossref

Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer

Lingjie Hou, Siyuan Zhang, Wenwen Yu, Xuena Yang, Meng Shen, Xishan Hao, Xiubao Ren, Qian Sun

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiad138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Lingjie Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, No. 45 Binshui Road, Hexi District, Tianjin 3…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Natural Science Foundation, Haihe Laboratory of Cell Ecosystem Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is the most pervasive lung cancer subtype. Recent studies have shown that immune checkpoint inhibitors achieved favorable clinical benefits in resectable NSCLC; however, the associated mechanism remains unclear. The role of T cells in antitumor immunity has received considerable attention, while the antitumor effects of tumor-infiltrating B cells (TIBs) in NSCLC remain poorly understood. Here, we conducted a single-cell RNA sequencing analysis of immune cells isolated from 12 patients with stage IIIA NSCLC to investigate B cell subtypes and their functions following neoadjuvant chemoimmunotherapy. We confirmed the simultaneous existence of the 4 B cell subtypes. Among them, memory B cells were found to be associated with a positive therapeutic effect to neoadjuvant chemoimmunotherapy. Furthermore, we found that G protein–coupled receptor 183 was most prevalent in memory B cells and associated with a positive therapeutic response. Multiplex immunofluorescence and flow cytometry experiments in an additional cohort of 22 treatment-naïve and 30 stage IIIA/IIIB NSCLC patients treated with neoadjuvant chemoimmunotherapy verified these findings. Overall, our analysis revealed the functions of TIBs and their potential effect on clinical treatment in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoadjuvant TherapyAntibodies, Monoclonal, HumanizedSingle-Cell AnalysisLymphocytes, Tumor-InfiltratingHumansMaleFemaleMiddle AgedTranscriptomeB-LymphocytesAgedAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

GPR183memory B cellsneoadjuvant chemoimmunotherapynon-small cell lung cancer

Substanzen

Antibodies, Monoclonal, Humanizedpembrolizumab

Autor:innen und Institutionen

  • National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.
  • Key Laboratory of Cancer Prevention and Therapy, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.
  • Tianjin's Clinical Research Center for Cancer, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.
  • Key Laboratory of Cancer Immunology and Biotherapy, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.
  • Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.
  • Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, No. 45 Binshui Road, Hexi District, Tianjin 300060, China.

Förderung

  • National Natural Science Foundation of China
  • Tianjin Natural Science Foundation
  • Haihe Laboratory of Cell Ecosystem Innovation Fund
  • Tianjin Key Medical Discipline

Zitieren

APA

Hou, L., Zhang, S., Yu, W., Yang, X., Shen, M., Hao, X., Ren, X., & Sun, Q. (2024). Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiad138

Vancouver

Hou L, Zhang S, Yu W, Yang X, Shen M, Hao X, et al. Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiad138

BibTeX
@article{Hou2024,
  author = {Hou, Lingjie and Zhang, Siyuan and Yu, Wenwen and Yang, Xuena and Shen, Meng and Hao, Xishan and Ren, Xiubao and Sun, Qian},
  title = {Single-cell transcriptomics reveals tumor-infiltrating B cell function after neoadjuvant pembrolizumab and chemotherapy in non-small cell lung cancer},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiad138}
}
Kostenlos starten →